Pal Pal SK SK Bergerot Bergerot P P Dizman Dizman N N Responses to alectinib in ALK-rearranged papillary renal cell carcinoma Responses to alectinib in ALK-rearranged papillary renal cell carcinoma Eur Urol Eur Urol 2018 2018 74 74 124 124 128 128 supplied-pmid 29685646? Here, ALK is linked to papillary renal cell carcinoma.